How should I use Datroway(DatopotamabDeruxtecan-dlnk)?

The recommended dosage and administration details for DATROWAY are outlined here.

Dosage and Administration

The recommended dosage of DATROWAY is 6 mg/kg (maximum 540 mg for patients ≥90 kg) administered as an intravenous infusion once every three weeks. Premedication includes antihistamines, antipyretics, antiemetics, and lubricating eye drops. Patients should use a steroid-containing mouthwash and hold ice chips in the mouth during infusion. Dose adjustments or discontinuation may be required based on adverse reactions. Infusions are given over 90 minutes initially, then 30 minutes if tolerated, with post-infusion monitoring.

DatopotamabDeruxtecan-dlnk(Datroway)
Treatment of unresectable or metastatic HR-positive, HER2-negative breast cancer in adults who have received prior endocrine therapy and chemotherapy.
RELATED ARTICLES
How to Use Datopotamab deruxtecan (Datroway)

Datopotamab deruxtecan (Datroway) is a Trop-2-targeted antibody-drug conjugate (ADC) indicated for the treatment of...

Monday, October 20th, 2025, 11:46
/ 1
1 in total
Contact Medical Consultant
Global Drug Search
Clinical recruitment
overseas medical treatment
Remote consultation
Note: Our medical consultant will contact you as soon as possible. We promise to strictly protect your privacy.
Click to submit medical consultant
Contact Us
Mailbox:Info@Lucius.La
Welcome To Consult
Ucius Pharmaceuticals (Lao) Co.,Ltd All Rights Reserved